In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter Soelkner, Managing Director at Vetter.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering:
The fascinating and humble origin story of one of the world’s most well respected sterile filling specialists.
Peter’s journey of leading Vetter in becoming a $1bn, 5500 person family-owned CDMO....
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter Soelkner, Managing Director at Vetter.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering:
- The fascinating and humble origin story of one of the world’s most well respected sterile filling specialists.
- Peter’s journey of leading Vetter in becoming a $1bn, 5500 person family-owned CDMO...alongside a fellow Managing Director.
- How the DNA of a culture becomes a critical competent of global business growth and consistent client delivery.
- Key future industry trends, including the challenge of preparing for the ‘colourful scenery of biotechs in the next 10 years’ - meaning the need to have the flexibility to deal with ultra orphan drug products and high volume products needing high speed lines.
Peter Soelkner has been a Managing Director of Vetter Pharma-Fertigung GmbH & Co. KG since June 2008. In 2009, he was also appointed Managing Director of Vetter Pharma International GmbH, the company’s marketing and sales organization. Soelkner graduated from the University of Dortmund, Germany, in 1992 with a degree in chemical engineering and earned an MBA from Columbia University, New York, in 2001. Before joining Vetter, he held positions in Germany and North America at Sartorius AG and Sartorius North America Inc., in R&D, marketing, key account management, and general management roles. At Vetter, from 2003 to 2007, Soelkner managed the company’s key account program and global end-to-end supply chain. He left the company for a year to serve as Vice President of global key account management at Sartorius Stedim Biotech (USA) before returning to Vetter in 2008.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is funded by ramarketing. An international content, design and digital agency that helps companies in life sciences get noticed.
We are also proudly supported by Zymewire, which is the leader in actionable sales intelligence for life science Business development professionals. In fact, thousands of life science BD professionals start their day with sales signals from Zymewire. Learn more at tryzymewire.com
View more
